Cardiovascular Morbidity During Treatment of Overactive Bladder With B3 Agonists

NCT02622555 · clinicaltrials.gov ↗
COMPLETED
Status
221
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Karolinska Institutet